{"date": "2018-01-17_21:00:19", "url": "http://www.eurekalert.org/pub_releases/2017-01/msh-msr011717.php", "year": "Wed, 18 Jan 2017 05:00:00 GMT", "text": ["experimental", "biology", "2017april", "22", "26", "2017chicago", "il2018", "aaas", "annual", "meeting", "february", "15", "19", "2018austin", "tx", "new", "york", "ny", "january", "18", "2017", "international", "phase", "3", "trial", "found", "drug", "regorafenib", "improved", "survival", "patients", "advanced", "hepatocellular", "carcinoma", "hcc", "form", "liver", "cancer", "giving", "people", "previously", "options", "better", "chance", "survival", "results", "study", "included", "researchers", "tisch", "cancer", "institute", "icahn", "school", "medicine", "mount", "sinai", "recently", "published", "online", "lancet", "trial", "funded", "bayer", "included", "152", "sites", "21", "40", "percent", "hcc", "cases", "diagnosed", "advanced", "stages", "point", "hcc", "particularly", "difficult", "treat", "trial", "provides", "evidence", "regorafenib", "first", "systemic", "treatment", "patients", "whose", "hcc", "progressed", "treatment", "sorafenib", "drug", "proven", "clinical", "benefit", "study", "tested", "regorafenib", "effectiveness", "therapy", "573", "patients", "previously", "treated", "sorafenib", "194", "given", "placebo", "regorafenib", "multikinase", "inhibitor", "significantly", "improved", "overall", "survival", "months", "placebo", "months", "regorafenib", "two", "patients", "treated", "regorafenib", "tumor", "shrink", "undetectable", "level", "according", "study", "study", "represents", "breakthrough", "management", "hepatocellular", "carcinoma", "since", "provides", "evidence", "clinical", "benefits", "area", "unmet", "medical", "need", "said", "josep", "llovet", "md", "founder", "director", "liver", "cancer", "program", "professor", "medicine", "liver", "diseases", "icahn", "school", "medicine", "mount", "sinai", "regorafenib", "shown", "improve", "survival", "patients", "advanced", "hepatocellular", "carcinoma", "progressing", "sorafenib", "previously", "treatment", "available", "dr", "llovet", "member", "clinical", "trial", "steering", "committee", "charissa", "chang", "md", "assistant", "professor", "medicine", "liver", "diseases", "icahn", "school", "medicine", "principal", "investigator", "mount", "sinai", "testing", "success", "trial", "opens", "field", "testing", "drugs", "treatment", "hcc", "provides", "rationale", "test", "regorafenib", "treatment", "combination", "therapies", "administered", "directly", "tumor", "diseased", "liver", "patients", "earlier", "stage", "hcc", "according", "llovet", "trial", "regorafenib", "manageable", "adverse", "events", "according", "paper", "january", "bayer", "announced", "food", "drug", "administration", "fda", "granted", "priority", "review", "status", "stivarga", "regorafenib", "systemic", "treatment", "patients", "hepatocellular", "carcinoma", "research", "also", "presented", "european", "society", "medical", "oncology", "world", "congress", "gastrointestinal", "cancer", "cancer", "primary", "cause", "deaths", "worldwide"], "title": "Mount Sinai researchers involved in successful phase 3 trial of drug for liver cancer | EurekAlert! Science News", "source": "The Mount Sinai Hospital / Mount Sinai School of Medicine"}